Full Papers
different NaCl and BSA concentrations at 25, 30, and 378C. Bio-
transformations were started with the addition of substrate
(0.5 mm (Z)-undec-9-enoic acid, 1% finale DMSO concentration).
After 28 h of incubation at 800 rpm, the reactions were quenched
by the addition of HCl (20 mL, 1m) and extracted as described
above. Substrate conversion and product formation was analyzed
by GC-FID. The optimized conditions for (Z)-undec-9-enoic acid
conversion were evaluated by MODDE, applying tools for analysis
and prediction.
H), 1.60–1.66 (m, 2H, 3-H), 2.34 (t, J=7.5 Hz, 2H, 2-H), 3.77–
3.83 ppm (sext, J=6 Hz, 1H, 10-H).
Stereoselectivity of (Z)-undec-9-eoic acid hydration
Purified 10-hydroxyundecanoic acid (25 mg, 0.125 mmol) was dis-
solved in trimethylsulfonium hydroxide solution (TMSH, 1 mL,
0.25m in methanol) for the derivatization of the free carboxyl
group. After 1 h of incubation at 408C and 800 rpm, formic acid (>
98%, 5 mL, 46 gmolÀ1, ꢀ0.125 mmol) was added to remove the
surplus TMSH. After 30 min of incubation at room temperature and
300 rpm, the solution was transferred to a 5 mL pear-shaped flask
and the volatile compounds were removed by using a rotary evap-
orator.
Upscaling of (Z)-undec-9-enoic acid conversion
TB medium (5 L) with kanamycin (30 mgmLÀ1 final kanamycin con-
centration) was inoculated with preculture of E. coli BL21 DE3
pET28a(+)/Em-OAH (200 mL) to an OD600 of 0.05. Cells were culti-
vated at 378C and 800 rpm with 8 LminÀ1 aeration rate. The pH
value was kept at 7.2 by addition of ammonium hydroxide (28%)
and phosphoric acid (10%). For induction of heterologous protein
expression, the temperature was reduced to 308C and IPTG was
added to a final concentration of 0.5 mm at an OD600 of 5.5.
MgSO4·7H2O (25 mL, 1m), trace solution (2.5 mL) containing
CaCl2·2H2O (0.38 gLÀ1), ZnSO4·7H2O (0.18 gLÀ1), MnSO4·H2O
The stereoselectivity of 10-OH-undecanoic acid hydration by Em-
OAH was examined by Mosher ester analysis by applying a modi-
fied protocol by Hoye et al.[54] TMSH-derivatized product (5 mg,
ꢀ0.025 mmol) was dissolved in deuterated chloroform (1 mL, dried
with Na2SO4) in a 2 mL glass vial. Anhydrous pyridine (40 mL,
ꢀ0.5 mmol, 20 equiv) and (S)-(+)-a-methoxy-a-trifluoromethylphe-
nylacetyl chloride (S-(+)-MTPA-Cl, 74 mL, ꢀ0.4 mmol, 16 equiv) was
added and the reaction was stirred for 3 h at room temperature.
The same protocol was applied for the derivatization with R-(À)-
MTPA-Cl. Aliquots (600 mL) of each solution were analyzed by NMR
spectroscopy (500 Hz, 1H).
(0.1 gLÀ1),
Na2·ETDA
(20.1 gLÀ1),
FeCl3·6H2O
(16.7 gLÀ1),
CuSO4·5H2O (0.15 gLÀ1), and CoCl2·6H2O (0.18 gLÀ1), as well as
(NH4)2HPO4 (150 mL, 2.5m) were added to the culture. Glycerol
(86%) served as the carbon source with a feeding rate of 15 ghÀ1
,
which was increased to 22 ghÀ1 10 h after induction. Cells were
harvested after 23 h of incubation at a final OD600 of 44 and pellets
were stored at À208C.
Conversion of 1-decene
1-Decene biotransformations were performed in citrate buffer
(50 mm, pH 6) on the 500 mL scale in 2 mL glass vials as reaction
tubes. E. coli BL21 (DE3) pET28a(+) served as the negative control.
Expression cultures were thawed on ice, resuspended in citrate
buffer, and disrupted by sonication for lysate assays. Cell suspen-
sion (50 mgmLÀ1) and protein (3.8 mgmLÀ1) served for whole cell
and lysate biotransformations, respectively. Glucose (100 mm), FAD
(0.3 mm), NADH (3 mm), and DTT (2 mm) were applied for the de-
tailed analysis of MODDE-optimized conditions. Glucose (100 mm)
and FAD (0.3 mm) were applied for the direct comparison of whole
cells and lysate under optimized and non-optimized conditions.
Reactions were started by the addition of substrate and dummy
substrate (0.5 mm 1-decene and 0.5 mm hexanoic acid, respective-
ly) with 1% final DMSO concentration and incubated at 258C and
800 rpm. Biotransformation samples (in triplicate) were quenched
by addition of NaOH (20 mL, 1m) and extracted twice with MTBE
(500 mL) and 1-octanol (500 mm) as internal standard. After each ex-
traction step, 300 mL of the organic phase was collected and direct-
ly analyzed by GC/GC-MS.
Upscaling of (Z)-undec-9-enoic acid conversion was performed
with 200 mg fatty acid substrate (1 mm final concentration, 1%
final DMSO concentration) in a 2 L Schott flask under the opti-
mized conditions (50 mgmLÀ1 biomass, 100 mm glucose, 0.3 mm
FAD, and 3 mm NADH). The biotransformation was started with the
addition of substrate and incubated at 308C and 180 rpm. After
two and three days of incubation, samples (500 mL, in triplicate)
were taken and prepared as described above. Substrate conversion
and product formation was analyzed by GC-FID. After three days of
incubation, the biotransformation was stopped with HCl (40 mL,
5m) and fatty acids were extracted by adding the equivalent
volume of MTBE. The organic phase was collected and the aque-
ous phase was extracted three times with MTBE (600 mL). The or-
ganic phases were combined, concentrated in vacuo, and stored at
48C.
The extracted biotransformation product was dissolved in the
mobile phase (98% dichloromethane with 2% methanol and 1%
acetic acid as additive) and purified by column chromatography
(40 cm length, 5 cm diameter, 300 g silica gel 60). Purification frac-
tions were collected and analyzed by thin layer chromatography
(pre-coated TLC sheets ALUGRAMꢃXtra SIL G/UV254; 0.2 mm, silica
gel 60). TLC sheets were developed in phosphomolybdic acid hy-
drate (5 g in 50 mL ethanol) and by subsequent heating. Samples
of each fraction were prepared for GC-MS analysis as described
above. Product fractions were pooled and concentrated in vacuo.
A light-brown powder (132 mg) was obtained as the product with
>95% purity (YP/S=66%, YP/B =0.0024). Extracted and purified 10-
hydroxyundecanoic acid (10 mg) was mixed with deuterated
chloroform (600 mL CDCl3) for NMR analysis (1H, 13C). 13C NMR
(125 MHz, CDCl3): d=23.4, 24.7, 25.7, 29.0, 29.1, 29.3, 29.5, 34.0,
For chiral GC analysis, acetic anhydride (250 mL) and a catalytic
amount of 4-dimethylaminopyridine (DMAP, 2 mg) were added to
the organic phase (600 mL). After 1 h of incubation at 258C and
800 rpm, water (300 mL) was added. The organic phase was trans-
ferred to a new reaction tube, dried over Na2SO4, and analyzed by
GC-FID (CP-Chirasil-Dex CB).
Analytics—GC and GC-MS
Derivatized fatty acid samples were analyzed by GC by using a DB-
5 polyphenylmethylsiloxane column (30 m, 0.25 mm, 0.25 mm; Agi-
lent technologies, Santa Clara, USA) on a Shimadzu GC2010 Plus
(Shimadzu, Kyo¯to, Japan) equipped with an AOC 20s autosampler
and AOC 20i autoinjector (injection volume: 1 mL, split ratio: 1:10,
1
39.0, 68.0, 179.0 ppm; H NMR (500 MHz, CDCl3): d=1.18 (s, 1H, 11-
H), 1.19 (s, 2H, 11-H), 1.30–1.47 (m, 12H, 4-H, 5-H, 6-H, 7-H, 8-H, 9-
ChemCatChem 2017, 9, 1 – 10
7
ꢀ 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
These are not the final page numbers! ÞÞ